Literature DB >> 11023963

Fungal and parasitic infections of the eye.

S A Klotz1, C C Penn, G J Negvesky, S I Butrus.   

Abstract

The unique structure of the human eye as well as exposure of the eye directly to the environment renders it vulnerable to a number of uncommon infectious diseases caused by fungi and parasites. Host defenses directed against these microorganisms, once anatomical barriers are breached, are often insufficient to prevent loss of vision. Therefore, the timely identification and treatment of the involved microorganisms are paramount. The anatomy of the eye and its surrounding structures is presented with an emphasis upon the association of the anatomy with specific infection of fungi and parasites. For example, filamentous fungal infections of the eye are usually due to penetrating trauma by objects contaminated by vegetable matter of the cornea or globe or, by extension, of infection from adjacent paranasal sinuses. Fungal endophthalmitis and chorioretinitis, on the other hand, are usually the result of antecedent fungemia seeding the ocular tissue. Candida spp. are the most common cause of endogenous endophthalmitis, although initial infection with the dimorphic fungi may lead to infection and scarring of the chorioretina. Contact lens wear is associated with keratitis caused by yeasts, filamentous fungi, and Acanthamoebae spp. Most parasitic infections of the eye, however, arise following bloodborne carriage of the microorganism to the eye or adjacent structures.

Entities:  

Mesh:

Year:  2000        PMID: 11023963      PMCID: PMC88956          DOI: 10.1128/CMR.13.4.662

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  262 in total

1.  Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.

Authors:  L Coccia; D Calista; A Boschini
Journal:  Arch Ophthalmol       Date:  1999-02

2.  Intense photophobia caused by Arthrographis kalrae in a contact lens-wearing patient.

Authors:  E M Perlman; L Binns
Journal:  Am J Ophthalmol       Date:  1997-04       Impact factor: 5.258

3.  Reactivation of inflammatory lesions in ocular histoplasmosis.

Authors:  D Callanan; G E Fish; R Anand
Journal:  Arch Ophthalmol       Date:  1998-04

4.  Pneumocystis carinii choroidopathy. A new clinical entity.

Authors:  W R Freeman; J G Gross; J Labelle; K Oteken; B Katz; C A Wiley
Journal:  Arch Ophthalmol       Date:  1989-06

5.  Follow-up study of presumed ocular histoplasmosis.

Authors:  J D Gass; C P Wilkinson
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 May-Jun

6.  Some observations on the ocular pathology of onchocerciasis.

Authors:  E V Paul; L E Zimmerman
Journal:  Hum Pathol       Date:  1970-12       Impact factor: 3.466

7.  Pneumocystis carinii infection of the conjunctiva in a patient with acquired immune deficiency syndrome.

Authors:  G M Ruggli; R Weber; E P Messmer; R L Font; C Moll; W Bernauer
Journal:  Ophthalmology       Date:  1997-11       Impact factor: 12.079

8.  Natural history of experimental histoplasmic choroiditis in the primate. II. Histopathologic features.

Authors:  R E Smith; S Dunn; J V Jester
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-07       Impact factor: 4.799

9.  Fungal invasion of a therapeutic soft contact lens and cornea.

Authors:  G K Yamamoto; D Pavan-Langston; G C Stowe; D M ALbert
Journal:  Ann Ophthalmol       Date:  1979-11

10.  Loiasis: report of three cases and literature review.

Authors:  R D Gibbs
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

View more
  66 in total

1.  Aspergillus keratitis following corneal foreign body.

Authors:  B Fahad; M McKellar; M Armstrong; D Denning; A Tullo
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

Review 2.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

Review 3.  Toll-like receptors and corneal innate immunity.

Authors:  Ashok Kumar; Fu-Shin X Yu
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

4.  Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis.

Authors:  A Biglino; P Crivelli; E Concialdi; C Bolla; G Montrucchio
Journal:  Infection       Date:  2008-10-14       Impact factor: 3.553

5.  Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features.

Authors:  Jeena Mascarenhas; Prajna Lalitha; N Venkatesh Prajna; Muthiah Srinivasan; Manoranjan Das; Sean S D'Silva; Catherine E Oldenburg; Durga S Borkar; Elizabeth J Esterberg; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Ophthalmol       Date:  2013-11-05       Impact factor: 5.258

6.  Cornea as a tissue reservoir of Trypanosoma cruzi.

Authors:  Leidi Herrera; Clara Martínez; Hernán Carrasco; Ana Maria Jansen; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2006-12-20       Impact factor: 2.289

7.  Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi.

Authors:  P A Thomas; A K Leck; M Myatt
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 8.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 9.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

10.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.